Transcend Capital Advisors LLC Cuts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Transcend Capital Advisors LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,635 shares of the medical equipment provider’s stock after selling 21 shares during the period. Transcend Capital Advisors LLC’s holdings in Intuitive Surgical were worth $1,375,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of ISRG. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $26,000. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $36,000. Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at about $38,000. Finally, DT Investment Partners LLC grew its position in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after buying an additional 36 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Jamie Samath sold 188 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $101,332.00. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,720,023. The trade was a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock worth $3,587,582 in the last 90 days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Trading Down 2.4 %

ISRG stock opened at $591.79 on Friday. The company has a market capitalization of $210.78 billion, a P/E ratio of 92.32, a PEG ratio of 5.87 and a beta of 1.39. The business has a 50 day simple moving average of $565.45 and a 200-day simple moving average of $524.52. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several analyst reports. BTIG Research raised their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Royal Bank of Canada increased their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Barclays lifted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Wells Fargo & Company increased their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.